Zobrazeno 1 - 6
of 6
pro vyhledávání: '"van Staveren MC"'
Autor:
van Staveren MC, Theeuwes-Oonk B, Guchelaar HJ, van Kuilenburg AB, Maring JG, van Staveren, Maurice C, Theeuwes-Oonk, Barbara, Guchelaar, Henk Jan, van Kuilenburg, André B P, Maring, Jan Gerard
Publikováno v:
Cancer Chemotherapy & Pharmacology; Dec2011, Vol. 68 Issue 6, p1611-1617, 7p
Autor:
de With M; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; Department of Clinical Chemistry, Erasmus Medical Center, Rotterdam, The Netherlands., Knikman J; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., de Man FM; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands., Lunenburg CATC; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Henricks LM; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Medical Oncology, Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, Leiden, The Netherlands., van Kuilenburg ABP; Laboratory Genetic Metabolic Diseases, Department of Clinical Chemistry, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam Gastroenterology Endocrinology Metabolism, University of Amsterdam, Amsterdam, The Netherlands., Maring JG; Department of Pharmacy, Isala Hospital, Zwolle, The Netherlands.; Isala Diaconessen Hospital, Meppel, The Netherlands., van Staveren MC; Department of Clinical Pharmacy and Toxicology, Treant Healthgroup, Scheper Hospital, Emmen, The Netherlands., de Vries N; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Rosing H; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Beijnen JH; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands., Pluim D; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Modak A; Cambridge Isotope Laboratories, Tewksbury, Massachusetts, USA., Imholz ALT; Department of Internal Medicine, Deventer Hospital, Deventer, The Netherlands., van Schaik RHN; Department of Clinical Chemistry, Erasmus Medical Center, Rotterdam, The Netherlands., Schellens JHM; Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Cats A; Division of Medical Oncology, Department of Gastrointestinal Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.; Leiden Network for Personalised Therapeutics (LNPT), Leiden, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands., Swen JJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.; Leiden Network for Personalised Therapeutics (LNPT), Leiden, The Netherlands., Meulendijks D; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Medical Oncology, Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Late Development Oncology, AstraZeneca, Cambridge, UK.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2022 Jul; Vol. 112 (1), pp. 62-68. Date of Electronic Publication: 2022 May 04.
Autor:
Lunenburg CA; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., van Staveren MC; Department of Pharmacy, Treant Healthgroup, The Netherlands.; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Guchelaar HJ; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands., Swen JJ; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
Publikováno v:
Pharmacogenomics [Pharmacogenomics] 2016 May; Vol. 17 (7), pp. 721-9. Date of Electronic Publication: 2016 May 16.
Autor:
van Staveren MC; Department of Clinical Pharmacy, Treant Healthgroup, Scheper Hospital, Emmen, The Netherlands., van Kuilenburg AB; Laboratory of Genetic Metabolic Diseases, Academic Medical Center, Amsterdam, The Netherlands., Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands., Meijer J; Laboratory of Genetic Metabolic Diseases, Academic Medical Center, Amsterdam, The Netherlands., Punt CJ; Department of Medical Oncology, Academic Medical Center, Amsterdam, The Netherlands., de Jong RS; Department of Oncology, Martini Hospital, Groningen, The Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, University Hospital of Leiden, Leiden, The Netherlands., Maring JG; Department of Pharmacy, Isala Diaconessen Hospital, Meppel and Bethesda Hospital,Hoogeveen, The Netherlands.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2016 Mar; Vol. 81 (3), pp. 553-61. Date of Electronic Publication: 2016 Jan 08.
Autor:
van Staveren MC; Department of Pharmacy, Treant Healthgroup, Location Scheper, Scheper Hospital Emmen, Boermarkeweg 60, 7824 AA, Emmen, The Netherlands, m.vanstaveren@sze.nl., Opdam F, Guchelaar HJ, van Kuilenburg AB, Maring JG, Gelderblom H
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2015 Jul; Vol. 76 (1), pp. 47-52. Date of Electronic Publication: 2015 May 10.
Autor:
van Staveren MC; Department of Pharmacy, Scheper Hospital Emmen and Röpcke Zweers Hospital Hardenberg, Emmen, The Netherlands., Guchelaar HJ, van Kuilenburg AB, Gelderblom H, Maring JG
Publikováno v:
The pharmacogenomics journal [Pharmacogenomics J] 2013 Oct; Vol. 13 (5), pp. 389-95. Date of Electronic Publication: 2013 Jul 16.